Abstract
Keywords:
SARS-CoV-2; edema; ies; interleukin-1; pyroptosis; vascular system injur.
MeSH terms
-
Animals
-
Antigens, CD / metabolism
-
COVID-19 / complications
-
COVID-19 / physiopathology*
-
COVID-19 Drug Treatment*
-
Cadherins / metabolism
-
Capillary Permeability
-
Caspase 1 / metabolism
-
Disease Models, Animal
-
Down-Regulation / drug effects
-
Edema / physiopathology
-
Edema / prevention & control
-
Endothelium, Vascular / drug effects
-
Enzyme Activation
-
Fibrosis / prevention & control
-
Interleukin 1 Receptor Antagonist Protein / therapeutic use*
-
Mice
-
Mice, Inbred C57BL
-
Mice, Transgenic
-
NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
-
Neutrophils / physiology
-
Pulmonary Circulation
-
Receptors, Interleukin-1 / antagonists & inhibitors
-
Receptors, Interleukin-1 / physiology*
-
SARS-CoV-2
-
Signal Transduction / drug effects
Substances
-
Antigens, CD
-
Cadherins
-
Interleukin 1 Receptor Antagonist Protein
-
NLR Family, Pyrin Domain-Containing 3 Protein
-
Nlrp3 protein, mouse
-
Receptors, Interleukin-1
-
cadherin 5
-
Casp1 protein, mouse
-
Caspase 1